These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8639857)

  • 1. Human erythrocytes bearing electroinserted CD4 neutralize infection in vitro by primary isolates of human immunodeficiency virus type 1.
    Tosi PF; Schwartz D; Sharma U; Mouneimne Y; Hannig J; Li G; McKinley G; Grieco M; Flexner CW; Lazarte J; Norse D; Nicolau C; Volsky DJ
    Blood; 1996 Jun; 87(11):4839-44. PubMed ID: 8639857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus.
    Zeira M; Tosi PF; Mouneimne Y; Lazarte J; Sneed L; Volsky DJ; Nicolau C
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4409-13. PubMed ID: 2034680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.
    Olinger GG; Saifuddin M; Spear GT
    J Virol; 2000 Sep; 74(18):8550-7. PubMed ID: 10954556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro infection of natural killer cells with different human immunodeficiency virus type 1 isolates.
    Chehimi J; Bandyopadhyay S; Prakash K; Perussia B; Hassan NF; Kawashima H; Campbell D; Kornbluth J; Starr SE
    J Virol; 1991 Apr; 65(4):1812-22. PubMed ID: 1672164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients.
    Busch MP; Lee TH; Heitman J
    Blood; 1992 Oct; 80(8):2128-35. PubMed ID: 1391964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection.
    Haponsaph R; Darden JM; Chantakulkij S; Sannoi N; de Souza MS; Brown AE; Birx DL; Polonis VR; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2004 Mar; 22(1):39-48. PubMed ID: 15366657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells.
    Røsok B; Voltersvik P; Larsson BM; Albert J; Brinchmann JE; Asjö B
    AIDS Res Hum Retroviruses; 1997 Jan; 13(1):79-85. PubMed ID: 8989430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-tropic human immunodeficiency virus (HIV) type 1 Nef protein enters human monocyte-macrophages and induces resistance to HIV replication: a possible mechanism of HIV T-tropic emergence in AIDS.
    Alessandrini L; Santarcangelo AC; Olivetta E; Ferrantelli F; d'Aloja P; Pugliese K; Pelosi E; Chelucci C; Mattia G; Peschle C; Verani P; Federico M
    J Gen Virol; 2000 Dec; 81(Pt 12):2905-2917. PubMed ID: 11086122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.
    Miller MD; Warmerdam MT; Gaston I; Greene WC; Feinberg MB
    J Exp Med; 1994 Jan; 179(1):101-13. PubMed ID: 8270859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human erythrocytes selectively bind and enrich infectious HIV-1 virions.
    Beck Z; Brown BK; Wieczorek L; Peachman KK; Matyas GR; Polonis VR; Rao M; Alving CR
    PLoS One; 2009 Dec; 4(12):e8297. PubMed ID: 20011536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-clade inhibition of human immunodeficiency virus type 1 primary isolates by monoclonal anti-CD4.
    Shearer MH; Timanus DK; Benton PA; Lee DR; Kennedy RC
    J Infect Dis; 1998 Jun; 177(6):1727-9. PubMed ID: 9607858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors.
    Surdo M; Cortese MF; Orlandi C; Di Santo F; Aquaro S; Magnani M; Perno CF; Casabianca A; Ceccherini-Silberstein F
    Antiviral Res; 2018 Dec; 160():165-174. PubMed ID: 30420339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism of restricted human immunodeficiency virus type 1 expression in human glial cells.
    Shahabuddin M; Bentsman G; Volsky B; Rodriguez I; Volsky DJ
    J Virol; 1996 Nov; 70(11):7992-8002. PubMed ID: 8892923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells.
    Thacker TC; Zhou X; Estes JD; Jiang Y; Keele BF; Elton TS; Burton GF
    J Virol; 2009 Jan; 83(1):150-8. PubMed ID: 18971284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication.
    Sloand EM; Young NS; Kumar P; Weichold FF; Sato T; Maciejewski JP
    Blood; 1997 Feb; 89(4):1357-63. PubMed ID: 9028959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of virus production in peripheral blood mononuclear cells from human immunodeficiency virus (HIV) type 1-seropositive donors by treatment with recombinant HIV-like particles.
    Haffar OK; Moran PA; Smithgall MD; Diegel ML; Sridhar P; Ledbetter JA; Zarling JM; Hu SL
    J Virol; 1992 Jul; 66(7):4279-87. PubMed ID: 1602544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD4 cytotoxic T lymphocyte (CTL) activity in HIV+ patients: flow cytometric analysis.
    Yamamura Y; Rodriguez N; Schwartz A; Eylar E; Yano N
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S133-44. PubMed ID: 8574141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
    Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
    Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.